Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:almaMater |
gptkb:University_of_Oxford
|
| gptkbp:birthDate |
1957-11-11
|
| gptkbp:deathDate |
2020-10-26
|
| gptkbp:doctoralAdvisor |
gptkb:Jack_Baldwin
|
| gptkbp:doctoralStudent |
gptkb:Shankar_Balasubramanian
|
| gptkbp:employer |
gptkb:University_of_Cambridge
|
| gptkbp:fellowOf |
gptkb:Academy_of_Medical_Sciences
gptkb:Royal_Society |
| gptkbp:field |
biochemistry
chemical biology |
| gptkbp:founder |
gptkb:Aqdot
gptkb:Sphere_Fluidics gptkb:Astex_Therapeutics |
| gptkbp:fullName |
gptkb:Christopher_Abell
|
| https://www.w3.org/2000/01/rdf-schema#label |
Chris Abell
|
| gptkbp:knownFor |
fragment-based drug discovery
microdroplet technology |
| gptkbp:memberOf |
gptkb:Department_of_Chemistry,_University_of_Cambridge
|
| gptkbp:nationality |
British
|
| gptkbp:occupation |
gptkb:academic
chemist |
| gptkbp:position |
Pro-Vice-Chancellor for Research at University of Cambridge
Professor of Biological Chemistry |
| gptkbp:spouse |
gptkb:Sue_Abell
|
| gptkbp:bfsParent |
gptkb:Sir_Shankar_Balasubramanian
|
| gptkbp:bfsLayer |
5
|